Vickers Vantage Corp. I Contracts & Agreements
74 Contracts & Agreements
- Business Finance (45 contracts)
- Business Operations (7)
- Human Resources (8)
- Mergers & Acquisitions (1)
- Real Estate (1)
- Uncategorized (12)
- Form of Representative Warrant (Filed With SEC on March 5, 2024)
- Form of Common Warrant (Filed With SEC on March 5, 2024)
- Underwriting Agreement, dated February 29, 2024, by and among Scilex Holding Company, Rodman & Renshaw LLC and StockBlock Securities LLC (Filed With SEC on March 5, 2024)
- Settlement Term Sheet, dated February 26, 2024, by and between Scilex Pharmaceuticals Inc., Sorrento Therapeutics, Inc. and Virpax Pharmaceuticals, Inc (Filed With SEC on February 27, 2024)
- Sales Agreement, dated as of December 22, 2023, by and among Scilex Holding Company, B. Riley Securities, Inc., Cantor Fitzgerald & Co. and H.C. Wainwright & Co., LLC (Filed With SEC on December 22, 2023)
- Severance and Change of Control Agreement, dated as of November 8, 2023, by and between Stephen Ma and Scilex Holding Company (Filed With SEC on November 14, 2023)
- Severance and Change of Control Agreement, dated as of November 9, 2023, by and between Henry Ji and Scilex Holding Company (Filed With SEC on November 14, 2023)
- Severance and Change of Control Agreement, dated as of November 8, 2023, by and between Jaisim Shah and Scilex Holding Company (Filed With SEC on November 14, 2023)
- Amendment to Convertible Debentures, dated as of October 11, 2023, by and between Scilex Holding Company and YA II PN, Ltd (Filed With SEC on October 11, 2023)
- Securities Purchase Agreement, dated September 21, 2023, by and between Scilex Holding Company, Oramed Pharmaceuticals Inc., and Acquiom Agency Services LLC (Filed With SEC on September 26, 2023)
- Senior Secured Promissory Note issued to Oramed Pharmaceuticals, Inc (Filed With SEC on September 26, 2023)
- Form of Scilex Holding Company Warrant to Purchase Common Stock (Filed With SEC on September 26, 2023)
- Registration Rights Agreement, dated September 21, 2023, by and between Scilex Holding Company and Oramed Pharmaceuticals Inc (Filed With SEC on September 26, 2023)
- Subsidiary Guarantee, dated September 21, 2023, made by certain of the Companys subsidiaries in favor of the holders of that certain Senior Secured Promissory Note dated as of the... (Filed With SEC on September 26, 2023)
- Security Agreement, dated September 21, 2023, by and among Scilex Holding Company, the Subsidiaries of the Company party thereto, Oramed Pharmaceuticals Inc. and Acquiom Agency... (Filed With SEC on September 26, 2023)
- Stock Purchase Agreement, dated September 21, 2023, by and between Scilex Holding Company and Sorrento Therapeutics, Inc (Filed With SEC on September 26, 2023)
- Assignment, Assumption and Release Agreement, dated September 21, 2023, by and among Scilex Holding Company, Oramed Pharmaceuticals Inc., Sorrento Therapeutics, Inc. and Scintilla... (Filed With SEC on September 26, 2023)
- Subordination Agreement, dated September 21, 2023, by and among eCapital Health Corp., Scilex Pharmaceuticals Inc. and Acquiom Agency Services LLC (Filed With SEC on September 26, 2023)
- Letter Agreement, dated September 21, 2023, by and among Scilex Holding Company, Sorrento Therapeutics, Inc. and Scintilla Pharmaceuticals, Inc (Filed With SEC on September 26, 2023)
- Letter Agreement, dated September 21, 2023, by and between Scilex Holding Company and Sorrento Therapeutics, Inc (Filed With SEC on September 26, 2023)
- Consulting Agreement, dated as of September 20, 2023, by and between Scilex Holding Company and Elizabeth Czerepak (Filed With SEC on September 22, 2023)
- Settlement Agreement, dated September 15, 2023, by and among Scilex Holding Company, Cove Lane Onshore Fund, LLC, HBC Investments LLC and Hudson Bay Capital Management LP (Filed With SEC on September 21, 2023)
- Junior Secured, Super-Priority Debtor-in-Possession Loan and Security Agreement, dated as of July 28, 2023, by (Filed With SEC on August 11, 2023)
- Form of Underwriting Agreement (Filed With SEC on July 13, 2023)
- Debtor-in-Possession Term Loan Facility Summary of Terms and Conditions, dated as of July 5, 2023, between Sorrento Therapeutics, Inc., Scintilla Pharmaceuticals, Inc. and Scilex... (Filed With SEC on July 7, 2023)
- Intercreditor and Subordination Agreement, dated as of July 5, 2023, by and among JMB Capital Partners Lending, LLC and Scilex Holding Company (Filed With SEC on July 7, 2023)
- Amended and Restated Industrial Lease, dated as of April 12, 2023, by and between Scilex Pharmaceuticals, Inc. and 960 San Antonio LLC (Filed With SEC on June 29, 2023)
- Guaranty Agreement, dated as of June 27, 2023, executed by Scilex Holding Company in favor of eCapital Healthcare Corp (Filed With SEC on June 27, 2023)
- Credit and Security Agreement, dated as of June 27, 2023, by and between Scilex Pharmaceuticals Inc. and eCapital Healthcare Corp (Filed With SEC on June 27, 2023)
- Scilex Holding Company 2022 Equity Incentive Plan, as amended (Filed With SEC on May 5, 2023)
- Third Convertible Debenture, dated as of April 20, 2023, executed by Scilex Holding Company (Filed With SEC on April 20, 2023)
- Second Convertible Debenture, dated as of April 11, 2023, executed by Scilex Holding Company (Filed With SEC on April 11, 2023)
- Registration Rights Agreement, dated as of March 21, 2023, by and between Scilex Holding Company and YA II PN, Ltd (Filed With SEC on March 21, 2023)
- Securities Purchase Agreement, dated as of March 21, 2023, by and between Scilex Holding Company and YA II PN, Ltd (Filed With SEC on March 21, 2023)
- Convertible Debentures, dated as of March 21, 2023, executed by Scilex Holding Company (Filed With SEC on March 21, 2023)
- Amended and Restated Standby Equity Purchase Agreement, dated as of February 8, 2023, by and between Scilex Holding Company and YA II PN, LTD (Filed With SEC on February 9, 2023)
- Form of Restricted Stock Unit Award Grant Notice and Award Agreement under the Scilex Holding Company 2023 Inducement Plan (Filed With SEC on January 17, 2023)
- Form of Stock Option Grant Notice and Stock Option Agreement under the Scilex Holding Company 2023 Inducement Plan (Filed With SEC on January 17, 2023)
- Scilex Holding Company 2023 Inducement Plan (Filed With SEC on January 17, 2023)
- Standby Equity Purchase Agreement, dated as of January 8, 2023, by and between Scilex Holding Company and B. Riley Principal Capital II, LLC (Filed With SEC on January 9, 2023)
- Standby Equity Purchase Agreement, dated as of November 17, 2022, by and between Scilex Holding Company and YA II PN, LTD (Filed With SEC on November 18, 2022)
- Form of Indemnification Agreement of Scilex Holding Company (Filed With SEC on November 17, 2022)
- Amended and Restated Registration Rights Agreement, dated as of November 10, 2022, by and among Scilex Holding Company, Vickers Venture Fund VI Pte Ltd, Vickers Venture Fund VI... (Filed With SEC on November 17, 2022)
- Scilex Holding Company 2022 Equity Incentive Plan (Filed With SEC on November 17, 2022)
- Form of Stock Option Grant Notice and Stock Option Agreement under the Scilex Holding Company 2022 Equity Incentive Plan (Filed With SEC on November 17, 2022)
- Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the Scilex Holding Company 2022 Equity Incentive Plan (Filed With SEC on November 17, 2022)
- Scilex Holding Company 2022 Employee Stock Purchase Plan (Filed With SEC on November 17, 2022)
- Debt Contribution Agreement, dated as of October 17, 2022, by and among Vickers Vantage Corp. I, Vickers Venture Fund VI (Plan) Pte Ltd and Vickers Venture Fund VI Pte Ltd (Filed With SEC on October 18, 2022)
- Amendment No. 1 to Sponsor Support Agreement, dated as of September 12, 2022, by and among Vickers Vantage Corp. I, Scilex Holding Company and each of the Persons set forth on... (Filed With SEC on September 14, 2022)
- Stockholder Agreement, dated as of September 12, 2022, by and among Sorrento Therapeutics, Inc. and Vickers Vantage Corp. I (Filed With SEC on September 14, 2022)
- Amendment No. 1 to Agreement and Plan of Merger, dated as of September 12, 2022, by and among Vickers Vantage Corp. I, Vantage Merger Sub Inc. and Scilex Holding Company (Filed With SEC on September 14, 2022)
- Promissory Note (Filed With SEC on April 11, 2022)
- Promissory Note (Filed With SEC on April 11, 2022)
- Amendment to Underwriting Agreement dated as of March 17, 2022 by and among Maxim Group LLC as representative of the underwriters named on Schedule A of the Agreement, and Vickers... (Filed With SEC on March 21, 2022)
- Form of Promissory Note (Filed With SEC on January 7, 2022)
- Description of the Registrants Securities (Filed With SEC on March 31, 2021)
- Form of Indemnification Agreement (Filed With SEC on January 11, 2021)
- Administrative Services Agreement (Filed With SEC on January 11, 2021)
- Registration Rights Agreement between the Company and certain security holders (Filed With SEC on January 11, 2021)
- Investment Management Trust Agreement between the Company and Continental Stock Transfer & Trust Company (Filed With SEC on January 11, 2021)
- Warrant Agreement between the Company and Continental Stock Transfer & Trust Company (Filed With SEC on January 11, 2021)
- Underwriting Agreement between the Company and Maxim Group LLC, as representative of the underwriters (Filed With SEC on January 11, 2021)
- Form of Underwriting Agreement (Filed With SEC on December 28, 2020)
- Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on December 28, 2020)
- Specimen Unit Certificate (Filed With SEC on December 15, 2020)
- Form of Subscription Agreement (Filed With SEC on December 15, 2020)
- Form of Administrative Services Agreement (Filed With SEC on December 15, 2020)
- Form of Indemnity Agreement (Filed With SEC on December 15, 2020)
- Form of Registration Rights Agreement between the Registrant and securityholders (Filed With SEC on December 15, 2020)
- Form of Investment Management Trust Agreement between Continental Stock Transfer& Trust Company and the Registrant (Filed With SEC on December 15, 2020)
- Form of Letter Agreement among the Registrant and each of the sponsors, directors and officers of the Registrant (Filed With SEC on December 15, 2020)
- Form of Warrant Agreement between Continental Stock Transfer& Trust Company and the Registrant (Filed With SEC on December 15, 2020)
- Specimen Warrant Certificate (Filed With SEC on December 15, 2020)
- Specimen Ordinary Shares Certificate (Filed With SEC on December 15, 2020)